# HIF-1α suppresses SNPH expression to facilitate liver metastasis of colorectal cancer through regulating mitochondrial dynamics and filopodia formation

**Authors:** Lei Zhan, Xiaoxi Li, Xiaoyan Li, Qian Fei, Yue Jin, Jiaxing Yu, Luyao Tian, Feifei Li, Chunning Li, Qian Dong, Yong Zhang, Shulan Sun, Jingdong Zhang

PMC · DOI: 10.1038/s41419-026-08551-1 · Cell Death & Disease · 2026-03-26

## TL;DR

This study shows how HIF-1α reduces SNPH levels in colorectal cancer, promoting liver metastasis through mitochondrial changes and cell movement.

## Contribution

The novel finding is the HIF-1α/miR-130a-3p/SNPH axis regulating CRC liver metastasis via mitochondrial dynamics and ROS.

## Key findings

- Low SNPH expression correlates with poor CRC prognosis and promotes cell migration and invasion.
- HIF-1α activates miR-130a-3p, which targets SNPH mRNA to reduce its levels and enhance metastasis.
- SNPH overexpression inhibits liver metastasis by promoting mitochondrial fusion and reducing ROS.

## Abstract

Colorectal cancer (CRC) is a leading cause of cancer-associated deaths, with liver metastases developing in about 50% of patients. Mitochondrial dynamics play critical roles in a diverse range of cellular functions, including cell migration and cancer metastasis. However, the influence of mitochondrial dynamics deregulation in CRC liver metastasis is incompletely understood. Through multiple transcriptomic data analysis and validation, we found that low expression of SNPH significantly correlated with poor prognosis of CRC patients. SNPH knockdown altered mitochondrial dynamics to increase cell migration and invasion by promoting filopodia formation. Moreover, the reduced levels of SNPH were linked to HIF-1α expression. Luciferase reporter assay revealed that HIF-1α transcriptionally activated miR-130a-3p expression, which targeted SNPH mRNA to inhibit its protein levels. Furthermore, miR-130a-3p inhibitor suppressed SNPH downregulation, filopodia formation, and CRC cells metastasis under hypoxic conditions. Mechanistically, SNPH downregulation promoted ROS production, resulting in the activation of the AKT/cdc42 pathway and downstream PAK1/Cofilin cascade. The overexpression of SNPH increased mitochondrial fusion and deterred the liver metastasis ability of CRC cells in vivo. Together, our results suggest that SNPH suppression imposed by the HIF-1α/miRNA-130a-3p axis under hypoxia conditions promotes the liver metastasis of CRC cells by activating the AKT/cdc42-PAK1/Cofilin cascade through mitochondrial dynamics-mediated ROS production.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], SNPH (syntaphilin) [NCBI Gene 9751], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], CDC42 (cell division cycle 42) [NCBI Gene 998], PAK1 (p21 (RAC1) activated kinase 1) [NCBI Gene 5058], CFL1 (cofilin 1) [NCBI Gene 1072]
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, ACADL (acyl-CoA dehydrogenase long chain) [NCBI Gene 33] {aka ACAD4, LCAD}, CRMP1 (collapsin response mediator protein 1) [NCBI Gene 1400] {aka CRMP-1, DPYSL1, DRP-1, DRP1, ULIP-3}, NRP1 (neuropilin 1) [NCBI Gene 8829] {aka BDCA4, CD304, NP1, NRP, VEGF165R}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, MAOB (monoamine oxidase B) [NCBI Gene 4129], GPX1 (glutathione peroxidase 1) [NCBI Gene 2876] {aka GPXD, GSHPX1}, Snph (syntaphilin) [NCBI Gene 241727] {aka 6430515A01, mKIAA0374}, MIR130A (microRNA 130a) [NCBI Gene 406919] {aka MIRN130A, miRNA130A, mir-130a}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, EFHD1 (EF-hand domain family member D1) [NCBI Gene 80303] {aka MST133, MSTP133, PP3051, SWS2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MIR130B (microRNA 130b) [NCBI Gene 406920] {aka MIRN130B, mir-130b}, ACADSB (acyl-CoA dehydrogenase short/branched chain) [NCBI Gene 36] {aka 2-MEBCAD, ACAD7, SBCAD}, HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase) [NCBI Gene 3155] {aka HL, HMGCL1}, MIR301A (microRNA 301a) [NCBI Gene 407027] {aka MIR301, MIRN301, MIRN301A, mir-301a}, CHPT1 (choline phosphotransferase 1) [NCBI Gene 56994] {aka CPT, CPT1}, PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}, Pak1 (p21 (RAC1) activated kinase 1) [NCBI Gene 18479] {aka PAK-1, Paka}, XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331] {aka API3, BIRC4, IAP-3, ILP1, MIHA, XLP2}, PRDX4 (peroxiredoxin 4) [NCBI Gene 10549] {aka AOE37-2, AOE372, HEL-S-97n, PRX-4}, SNPH (syntaphilin) [NCBI Gene 9751], HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2) [NCBI Gene 3158], CA9 (carbonic anhydrase 9) [NCBI Gene 768] {aka CAIX, MN}, MIR19B1 (microRNA 19b-1) [NCBI Gene 406980] {aka C13orf25, MIR19B, MIRH1, MIRHG1, MIRN19B1, miR-19b-1}, NUCB1 (nucleobindin 1) [NCBI Gene 4924] {aka CALNUC, NUC}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase) [NCBI Gene 1962] {aka ECHD, FRTS3, L-PBE, LBFP, MFE1, PBFE}, SARDH (sarcosine dehydrogenase) [NCBI Gene 1757] {aka BPR-2, DMGDHL1, SAR, SARD, SDH}, MIR19A (microRNA 19a) [NCBI Gene 406979] {aka C13orf25, MIRH1, MIRHG1, MIRN19A, hsa-mir-19a, miR-19a}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, PAK1 (p21 (RAC1) activated kinase 1) [NCBI Gene 5058] {aka IDDMSSD, PAKalpha, alpha-PAK, p65-PAK}, CYP27A1 (cytochrome P450 family 27 subfamily A member 1) [NCBI Gene 1593] {aka CP27, CTX, CYP27}, RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868] {aka RAB5}, Cdc42 (cell division cycle 42) [NCBI Gene 12540], RUNX3 (RUNX family transcription factor 3) [NCBI Gene 864] {aka AML2, CBFA3, PEBP2aC}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, GPT2 (glutamic--pyruvic transaminase 2) [NCBI Gene 84706] {aka ALT2, GPT 2, MRT49, NEDSPM}, MIR301B (microRNA 301b) [NCBI Gene 100126318] {aka MIRN301B, mir-301b}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, OTC (ornithine transcarbamylase) [NCBI Gene 5009] {aka OCTD, OTC1, OTCD, OTCase}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}
- **Diseases:** HCC (MESH:D006528), necrosis (MESH:D009336), ESCC (MESH:D004938), hypoxic (MESH:D002534), CRC (MESH:D015179), cervical and ovarian cancers (MESH:D010051), COAD (MESH:D029424), hemorrhage (MESH:D006470), Cancer (MESH:D009369), aggressiveness (MESH:D010554), death (MESH:D003643), LM (MESH:D009362), prostate cancer (MESH:D011471), glioblastoma (MESH:D005909), Hypoxia (MESH:D000860)
- **Chemicals:** hematoxylin (MESH:D006416), CO2 (MESH:D002245), pimonidazole (MESH:C033815), ATP (MESH:D000255), DAB (MESH:C000469), glutaraldehyde (MESH:D005976), alcohol (MESH:D000438), uranyl acetate (MESH:C005460), MitoSOX  Red (MESH:C000597839), lipid (MESH:D008055), Trizol (MESH:C411644), polyglycolic acid (MESH:D011100), CQ1 (-), paraffin (MESH:D010232), ROS (MESH:D017382), CMXRos (MESH:C107472), tribromoethanol (MESH:C062527), calcium (MESH:D002118), polyvinylidene fluoride (MESH:C024865), formaldehyde (MESH:D005557), streptomycin (MESH:D013307), superoxide (MESH:D013481), Mito-TEMPO (MESH:C555916), GTP (MESH:D006160), PBS (MESH:D007854), H2O2 (MESH:D006861), H&amp;E (MESH:D006371), oxygen (MESH:D010100), penicillin (MESH:D010406), Triton X-100 (MESH:D017830), crystal violet (MESH:D005840), Phalloidin (MESH:D010590), methanol (MESH:D000432)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C2210S, C2205S
- **Cell lines:** RKO — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0504), Flou-4 — Homo sapiens (Human), Ataxia telangiectasia syndrome, Finite cell line (CVCL_F083), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546), 293 T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), Caco2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039215/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039215/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039215/full.md

---
Source: https://tomesphere.com/paper/PMC13039215